Drug pricing is a prime candidate for value-based reforms, especially given the advent of new high-priced but potentially curative medications ill-suited to fee-for-service financing. CMS recently finalized changes to Medicaid’s Drug Rebate Program to facilitate and enable more value-based payment arrangements for drugs
In March 2021, California implemented a vaccine equity policy that prioritized COVID-19 vaccine allocation to communities identified as least advantaged by an area-based socioeconomic measure, the…
Learn how UnitedHealthcare’s National Advisory Board champions self-advocacy at every stage of life. Explore insights from experts in health care advocacy.
Many artificial intelligence (AI) payment proposals do not capture the rapid changes in how AI tools are being deployed. Instead of treating per use AI…
It is important to acknowledge that the responsibilities of the chief wellness officer represent a considerable volume of work that requires an expertise distinct from…
Assisted living has promised assistance and quality of living to older adults for more than eighty years. It is the largest residential provider of long-term…
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…
The regulations finalize a proposal to align the definition of “lawfully present” for DACA recipients with the definition of the term for other for deferred…
Three decades into the overdose crisis, US lawmakers are still trying to stem the rising tide of drug-related deaths. Promising recent developments, combined with the…
Women who are pregnant or recently gave birth are significantly more likely to be killed by an intimate partner than nonpregnant, nonpostpartum women of reproductive…
The managed care rule’s importance can hardly be overstated. As of 2022, three-quarters of states relied on managed care as a basic element of their…
